Contract services holds the largest share in the Computational Biology Market

 In 2018, the global computational biology market was valued at USD 2.9 billion, with a CAGR of 21.5 percent predicted over the forecast year of 2018-2026. Computational biology is an inter-disciplinary applied science that studies biological systems using mathematical, theoretical, and computer simulation models based on basic biology concepts. The rise in R&D for drug development, need for predictive models, use in population-based sequencing efforts like the human genome project, and government financing are all driving market expansion.



Computational bio-modeling entails using computer-assisted biological models to generalise methods, correctly display simulation, and review complexities in biological models in a virtual environment.. Computational genetics is a branch of computational biology that studies genomic homology and internal biological systems through genome sequencing. One of the most notable examples is the Human Genome Project, which successfully sequenced the whole human genome. Computational biology is used in neurology to see and comprehend three-dimensional simulation models of the brain by mapping complicated interconnected pathways. In the drug development process, computational pharmacology makes use of computer-aided visualisation techniques to simulate advanced drug-drug interactions.

Growing drug discovery R&D, demand for predictive models, use in population-based sequencing efforts like the human genome project, and government financing are all driving the market forward. For example, in March 2019, Ambrx Inc., a clinical-stage biopharmaceutical business specialising in protein therapies, struck a research and development agreement with BeiGene, Ltd., a commercial-stage pharmaceutical company involved in the development of immuno-oncology drugs. Ambrx has developed a unique Expanded Genetic Code platform that allows non-natural amino acids to be incorporated into protein sequences in E. coli and Chinese Hamster Ovary (CHO) cells. Both companies will use Ambrx's drug discovery platforms in conjunction with the latter's knowledge expertise and resource pool to produce clinically advanced biologics medications.

The German Translational Biodiversity Genomics Excellence Center was awarded a USD 20.0 million grant in January 2018 for high-quality sequencing of thousands of organisms over a seven-year period. Similarly, 23andMe got USD 1.7 million in funding from the National Institutes of Health's (NIH) National Human Genome Research Institute in October 2016 for a one-year period to develop sequencing panels for the  African American genomes. Furthermore, in 2016, the Canadian Ministry of Science announced a USD 4.0 million funding in 16 new computational biology initiatives. However, due to a scarcity of qualified specialists, the market's expansion is stifled.

Computational Biology Market Share Insights

Chemical Computing Group Inc., Compugen Ltd., Simulation Plus Inc., Genedata AG, Certara, Insilico Biotechnology AG, Accelrys, Rhenovia Pharma SAS, Entelos, Nimbus Discovery LLC, and Rhenovia Pharma SAS are some of the leading companies. To expand their worldwide reach, most organizations focus on strategic alliances, agreements, and mergers and acquisitions. Certara acquired BaseCase, a life sciences data visualization company.

Comments

Post a Comment

Popular posts from this blog

Continuous Glucose Monitoring (CGM) Devices Market -Dynamics and Forecast

Image
CGM (Continuous Glucose Monitoring) technology allows you to monitor your glucose levels 24 hours a day using a sensor that delivers the data to a MiniMed insulin pump. However, these devices also aid in diabetes management by lowering individual insulin dosages. These gadgets' integrated software provides users with information about food consumption, medication, physical activity, and ailments.  As a result, an increasing number of diabetic patients are relying on these devices to control and treat their condition, propelling market growth. A growing number of continuous glucose monitoring devices are being integrated with apps and software to treat people with diabetes mellitus, thanks to the development of digital medicines.The rising prevalence of diabetes mellitus has boosted the market for continuous glucose monitoring (CGM) devices. The Continuous Glucose Monitoring (CGM) Market is estimated to develop at a CAGR of 14% over the forecast period. High blood glucose levels oc...
Read more

YOU YES YOU!

Image
Welcome to Riya's  blog! HEY Everyone! So this is my my very first blog and  i am quite excited about it. WELL  I am  a 21 years old girl who sees the world through her eyes just like everyone else. I believe each of us have their own views and opinions about every little thing that we see through our eyes wide open and that is  what individuality is ! Having our own brains , hobbies,rights,skills , gifts ,flaws and i certainly believe that embracing them is one of the best things a human could do. Okay well so the topic on what  i am going to throw a little  light on here is not self love or self respect or being righteous , strong or anything like that , My topic here is going to be "YOU"   . "YOU" can be anyone here including me 'YOU' = "Individual" Isn't it so weird that in a world having  millions and millions of people  with their own "IDENTITIES " still lack " INDIVIDUALITY ". You know why? because...
Read more

Key Benefits of Breath Analyzer Market

Image
The Breath Analyzer is a gadget that uses a breath sample to determine an individual's Blood Alcohol Content (BAC). The test is based on the link between the amount of alcohol in the blood and the amount of alcohol in the breath going through the lungs. The use of breath analyzer equipment has increased as the trend for severe alcohol intake has increased, resulting in traffic accidents.  Government actions that favor the market are also propelling it forward. Breathalyzer devices are also gaining popularity as a result of the growing demand for accurate BAC (blood alcohol content) levels at work, as well as their non-invasive nature, which is driving up demand for breath analyzer equipment. It's a must-have tool for keeping track of drugs, alcohol, TB, and asthma. and other diseases hence; it is projected that the demand for this system should constantly rise.  Inaccurate analysis, on the other hand, might lead to wrong diagnosis, which is the market's main constrai...
Read more